Cutting-Edge Breakthrough: LB-P8 Granted FDA Fast Track for Primary Sclerosing Cholangitis
What To Know “Receiving Fast Track designation is a significant milestone in addressing the high unmet medical need for PSC, and it will facilitate the efficient development of LB-P8 by enabling close communication with the regulatory authority. Fast Track …